• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis.

作者信息

Kolijn P Martijn, Späth Florentin, Khouja Mouhamad, Hengeveld Paul J, van der Straten Lina, Darzentas Nikos, Hultdin Magnus, McKay James D, Pott Christiane, Vermeulen Roel C H, Langerak Anton W

机构信息

Department of Immunology, Laboratory Medical Immunology, Erasmus MC, Rotterdam, The Netherlands.

Division of Environmental Epidemiology and Veterinary Public Health, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.

出版信息

Blood. 2023 Oct 19;142(16):1399-1403. doi: 10.1182/blood.2023019609.

DOI:10.1182/blood.2023019609
PMID:37523714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10651867/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/10651867/bf10915624d3/BLOOD_BLD-2023-019609-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/10651867/533f5b09406b/BLOOD_BLD-2023-019609-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/10651867/5024113b87d4/BLOOD_BLD-2023-019609-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/10651867/bf10915624d3/BLOOD_BLD-2023-019609-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/10651867/533f5b09406b/BLOOD_BLD-2023-019609-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/10651867/5024113b87d4/BLOOD_BLD-2023-019609-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/10651867/bf10915624d3/BLOOD_BLD-2023-019609-gr2.jpg

相似文献

1
Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis.慢性淋巴细胞白血病自然病程中的遗传驱动因素早在诊断前16年就已出现。
Blood. 2023 Oct 19;142(16):1399-1403. doi: 10.1182/blood.2023019609.
2
Detection of t(14;18)(q32;q21) in B-cell chronic lymphocytic leukemia.B细胞慢性淋巴细胞白血病中t(14;18)(q32;q21)的检测
Arch Pathol Lab Med. 2005 Mar;129(3):410-1. doi: 10.5858/2005-129-410-DOQIBC.
3
Familial study of chronic lymphocytic leukemia: aggregation of different malignant processes in families with individuals affected with chronic lymphocytic leukemia.慢性淋巴细胞白血病的家族研究：慢性淋巴细胞白血病患者家庭中不同恶性病变的聚集情况。
Folia Med (Plovdiv). 2006;48(1):11-6.
4
[Leukemia: recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 5. Diagnosis and treatment of chronic lymphocytic leukemia].
Nihon Naika Gakkai Zasshi. 2013 Jul 10;102(7):1720-7. doi: 10.2169/naika.102.1720.
5
Chronic lymphocytic leukemia and hairy-cell leukemia--diagnosis and treatment: results of a consensus meeting of the German CLL Cooperative Group.
Ann Hematol. 1997 Jun;74(6):291-4. doi: 10.1007/s002770050303.
6
Prognostic significance of isolated t(8:14) in chronic lymphocytic leukemia.
Leuk Lymphoma. 2014 Mar;55(3):685-8. doi: 10.3109/10428194.2013.809078. Epub 2013 Jul 15.
7
Is chronic lymphocytic leukemia one disease?
Haematologica. 2002 Dec;87(12):1233-5.
8
Genetic lesions in chronic lymphocytic leukemia: what's ready for prime time use?慢性淋巴细胞白血病中的基因损伤：哪些已准备好投入实际应用？
Haematologica. 2010 Jan;95(1):12-5. doi: 10.3324/haematol.2009.016873.
9
IX. Chronic lymphocytic leukaemia: new genetic markers as prognostic factors.九、慢性淋巴细胞白血病：作为预后因素的新遗传标志物
Hematol Oncol. 2013 Jun;31 Suppl 1:57-9. doi: 10.1002/hon.2068.
10
Small lymphocytic lymphoma/chronic lymphocytic leukemia with chromothripsis in an old woman.一名老年女性患伴有染色体碎裂的小淋巴细胞淋巴瘤/慢性淋巴细胞白血病
Chin Med J (Engl). 2015 Apr 5;128(7):985-7. doi: 10.4103/0366-6999.154329.

引用本文的文献

1
Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer Subtypes.多队列高维蛋白质组学揭示淋巴癌亚型的早期风险标志物。
Res Sq. 2025 Aug 19:rs.3.rs-7400676. doi: 10.21203/rs.3.rs-7400676/v1.
2
BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism.在活跃的慢性淋巴细胞白血病克隆扩增过程中，BCL2蛋白逐渐下降：对维奈托克临床疗效的潜在影响及机制洞察
Lymphatics. 2024 Jun;2(2):50-78. doi: 10.3390/lymphatics2020005. Epub 2024 Mar 28.

本文引用的文献

1
The clonal evolution and natural history of MBL.甘露聚糖结合凝集素（MBL）的克隆进化与自然史
Blood. 2022 Oct 13;140(15):1660-1661. doi: 10.1182/blood.2022017940.
2
Progression and survival of MBL: a screening study of 10 139 individuals.MBL 的进展和生存情况：一项针对 10139 人的筛查研究。
Blood. 2022 Oct 13;140(15):1702-1709. doi: 10.1182/blood.2022016279.
3
Molecular map of chronic lymphocytic leukemia and its impact on outcome.慢性淋巴细胞白血病的分子图谱及其对预后的影响。
Nat Genet. 2022 Nov;54(11):1664-1674. doi: 10.1038/s41588-022-01140-w. Epub 2022 Aug 4.
4
Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21 chronic lymphocytic leukemia.亚克隆异质性揭示了IGLV3-21慢性淋巴细胞白血病的转化轨迹。
Blood Cancer J. 2022 Mar 30;12(3):49. doi: 10.1038/s41408-022-00650-4.
5
High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis.高危亚型慢性淋巴细胞白血病早在诊断前 16 年即可检测到。
Blood. 2022 Mar 10;139(10):1557-1563. doi: 10.1182/blood.2021012890.
6
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders.验证 EuroClonality-NGS DNA 捕获面板作为淋巴增生性疾病的综合基因组工具。
Blood Adv. 2021 Aug 24;5(16):3188-3198. doi: 10.1182/bloodadvances.2020004056.
7
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome.增殖史塑造了 B 细胞肿瘤的 DNA 甲基组，并预测了临床结果。
Nat Cancer. 2020 Nov;1(11):1066-1081. doi: 10.1038/s43018-020-00131-2. Epub 2020 Nov 2.
8
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.刻板亚群之间的高阶连接：对 CLL 中改善患者分类的影响。
Blood. 2021 Mar 11;137(10):1365-1376. doi: 10.1182/blood.2020007039.
9
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index.肿瘤突变负荷可预测慢性淋巴细胞白血病（CLL）和 CLL 国际预后指数以外的单克隆 B 细胞淋巴增生症患者的首次治疗时间。
Am J Hematol. 2020 Aug;95(8):906-917. doi: 10.1002/ajh.25831. Epub 2020 May 7.
10
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.慢性淋巴细胞白血病：2020 年诊断、风险分层和治疗更新。
Am J Hematol. 2019 Nov;94(11):1266-1287. doi: 10.1002/ajh.25595. Epub 2019 Oct 4.